Abstract

Arginine methylation mediated by protein arginine methyltransferases (PRMTs) is a post-translational modification of both histone and non-histone substrates related to diverse biological processes. PRMTs appear to be critical regulators in skeletal muscle physiology, including regeneration, metabolic homeostasis, and plasticity. Chronic inflammation is commonly associated with the decline of skeletal muscle mass and strength related to aging or chronic diseases, defined as sarcopenia. In turn, declined skeletal muscle mass and strength can exacerbate chronic inflammation. Thus, understanding the molecular regulatory pathway underlying the crosstalk between skeletal muscle function and inflammation might be essential for the intervention of muscle pathophysiology. In this review, we will address the current knowledge on the role of PRMTs in skeletal muscle physiology and pathophysiology with a specific emphasis on its relationship with inflammation.

Highlights

  • Aging is generally associated with numerous changes that may affect health and life span

  • Despite the current limitation in the number of studies investigating the function of protein arginine methyltransferases (PRMTs) in the muscle, accumulating evidence strongly suggests that this family of enzymes is emerging as key players in the regulation of muscle homeostasis and plasticity

  • PRMTs have been implicated in muscle development and regeneration and in the control of glucose/oxidative muscle metabolism

Read more

Summary

Arginine Methyltransferases and Inflammation in Muscle

Arginine methylation mediated by protein arginine methyltransferases (PRMTs) is a post-translational modification of both histone and non-histone substrates related to diverse biological processes. PRMTs appear to be critical regulators in skeletal muscle physiology, including regeneration, metabolic homeostasis, and plasticity. Chronic inflammation is commonly associated with the decline of skeletal muscle mass and strength related to aging or chronic diseases, defined as sarcopenia. Declined skeletal muscle mass and strength can exacerbate chronic inflammation. Understanding the molecular regulatory pathway underlying the crosstalk between skeletal muscle function and inflammation might be essential for the intervention of muscle pathophysiology. We will address the current knowledge on the role of PRMTs in skeletal muscle physiology and pathophysiology with a specific emphasis on its relationship with inflammation

INTRODUCTION
PROTEIN ARGININE METHYLTRANSFERASES
Roles of PRMTs in Muscle Regeneration and Metabolism
INFLAMMATION IN MUSCLE HOMEOSTASIS
Inflammation in Myogenesis and Muscle Regeneration
Inflammatory Cytokines in Muscle Protein Turnover
PRMTs IN INFLAMMATION
CONCLUSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.